GlassScriptPhysician profile
Gabriel Lopez
NPI 1326696899
$4,902.00
in general payments reported to CMS, 2019-2025
16 companies · $924 in 2025
The $924 reported for 2025 was more than what 79% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $555 · 2022: $113 · 2023: $1,971 · 2024: $1,339 · 2025: $924.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,220 · Travel and Lodging: $664 · Consulting Fee: $350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,220.48 |
| Travel and Lodging | $663.73 |
| Consulting Fee | $350.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,981.37 | 2023-2025 | Inspire |
| Jazz Pharmaceuticals INC. | $765.25 | 2021-2025 | |
| Avadel Cns Pharmaceuticals, LLC | $623.96 | 2023-2025 | Lumryz |
| Harmony Biosciences LLC | $388.81 | 2021-2025 | Wakix |
| Axsome Therapeutics, INC. | $350.36 | 2023-2025 | Sunosi |
| Idorsia Pharmaceuticals US INC | $242.65 | 2022-2024 | Quviviq |
| Eisai INC. | $155.52 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $124.96 | 2021 | |
| Fisher & Paykel Healthcare INC | $80.29 | 2024-2025 | Fisher & Paykel Healthcare |
| Novo Nordisk INC | $52.72 | 2025 | Wegovy |
| Merck Sharp & Dohme LLC | $34.16 | 2023 | Belsomra |
| Lilly USA, LLC | $26.64 | 2025 | Zepbound |
| 3b Medical, INC. | $24.13 | 2025 | Luna |
| Ucb, INC. | $19.27 | 2021 | |
| Azurity Pharmaceuticals, INC. | $18.74 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $13.17 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gabriel Lopez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.